The nonhuman primate as a model of developmental immunotoxicity

Human and Experimental Toxicology

Volumn 21, Issue 9-10, 2002, Pages 537-542

  Hendrickx, A G ^a   Makori, N ^a   Peterson, P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B and T lymphocytes; Nonhuman primate; Retinoic acid; Safety assessment; Spleen; Thymus

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CELL MARKER; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; FETOTOXICITY; FETUS; FETUS DEVELOPMENT; FLOW CYTOMETRY; GESTATION PERIOD; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOTOXICITY; INTESTINE; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOID ORGAN; LYMPHOID TISSUE; MACACA; MORPHOLOGY; NONHUMAN; ONTOGENY; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; THYMUS; THYMUS APLASIA;

AGE FACTORS; ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SYSTEM; ISOTRETINOIN; LYMPH NODES; LYMPHOID TISSUE; MACACA FASCICULARIS; MACACA MULATTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK ASSESSMENT; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TOXICOLOGY;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES;

EID: 0036759728     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327102ht294oa     Document Type: Article

References (16)

1. Hendrickx AG, Cukierski MA. Reproductive and developmental toxicology in nonhuman primates. In Graham CR ed. Preclinical safety of biotechnology products intended for human use. New York: Alan R. Liss, 1987: 73-88.
2. Henck JW, Hilbish KG, Serabian MA, et al. Reproductive toxicity testing of therapeutic biotechnology agents. Teratology 1996; 53: 185-95.
3. Hendrickx AG, Makori N, Peterson P. Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Hum Exp Toxicol 2000; 19: 1-7.
4. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837-41.
5. Hummler H, Korte R, Hendrickx AG. Induction of malformations in the cynomolgus monkey with 13-cis retinoic acid. Teratology 1990; 42: 263-72.
6. Korte R, Hummler H, Hendrickx AG. Importance of early exposure to 13-cis retinoic acid to induce teratogenicity in the cynomolgus monkey. Teratology 1993; 47: 37-45.
7. Makori N, Peterson PE, Wei X, Hummler H, Hendrickx AG. 13-cis-retinoic acid alters neural crest cells expressing Krox-20 and Pax-2 in macaque embryos. Anat Rec 1999; 255: 142-54.
8. Blackman M, Kappler J, Marrack P. The role of the T cell receptor in positive and negative selection of developing T cells. Science 1990; 248: 1335-41.
9. Mosley RL, Klein JR. Peripheral engraftment of fetal intestine into athymic mice sponsors T cell development: direct evidence for thymopoietic function of murine small intestine. J Exp Med 1992; 176: 1365-73.
10. Makori N, Tarantal AF, Lu FX, et al. Lymphocytes and antigen presenting cells ontogeny in fetal rhesus monkeys (second and). FASEB J 2001; 75 [Abstract].
11. Brown HE, Garcia MM, Harlan RE. A two focal plane method for digital quantification of nuclear immunoreactivity in large brain areas using NIH-image software. Brain Res Protoc 1998; 2: 264-72.
12. Spencer J, MacDonald TT, Finn T, Isaacson PG. The development of gut associated lymphoid tissue in the terminal ileum of fetal human intestine. Clin Exp Immunol 1986; 64: 536-43.
13. Takahashi K, Asagoe K, Zaishun J, et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated reticulum cells. Am J Pathol 1998; 153: 745-55.
14. Parrott DV, De Sousa MA, East J. Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice. J Exp Med 1966; 123: 191-204.
15. Parrott DM, Ferguson A. Selective migration of lymphocytes within the mouse small intestine. Immunology 1974; 26: 571-88.
16. Poussier P, Julius M. Speculation on the lineage relationships among CD4(-)8(+) gut-derived T cells and their role(s). Semin Immunol 1999; 11: 293-303.